Simultaneous quantitative analysis for phospholipids in human HDL and LDL using two internal standards by liquid chromatography/mass spectrometry

Analytical Letters

Volumn 39, Issue 5, 2006, Pages 957-972

  Hayakawa, Jun ^a   Ono, Takashi ^a   Hanasaki, Kohji ^a   Okabayashi, Yoshito ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

High density lipoproteins; Low density lipoproteins; Phospholipids

Indexed keywords

EID: 33646247639     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710600614172     Document Type: Article

References (23)

1. Bernhard, W., Linck, M., Creutzburg, H., Postle, A., Arining, D.A., Carrer, I.M., and Sewing, K.-Fr. 1994. High-performance liquid chromatographic analysis of phospholipids from different sources with combined fluorescence and ultraviolet detection. Anal. Biochem., 220: 172-180.
2. Bligh, E.G. and Dyer, W.J. 1959. A rapid method of total lipid extraction and purification. Can J. Biochem. Physiol., 37: 911-917.
3. Carrier, A., Parent, J., and Dupuis, S. 2000. Quantitation and characterization of phospholipids in pharmaceutical formulations by liquid chromatography-mass spectrometry. J. Chromatogr. A, 876: 97-109.
4. Edman, K. and Ericson, I. 1987. Phospholipid and fatty acid composition in mitochondria from spinach (Spinacia oleracea) leaves and petioles A comparative study. Biochem. J., 243: 575-578.
5. Han, X., Holtzman, D.M., and McKeel, D.W., Jr 2001. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem., 77: 1168-1180.
6. Hanasaki, K., Yamada, K., Yamamoto, S., Ishimoto, Y., Saiga, A., Ono, T., Ikeda, M., Notoya, M., Kamitani, S., and Arita, H. 2002. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation. J. Biol. Chem., 277: 29116-29124.
7. Hanasaki, K., Ono, T., Saiga, A., Morioka, Y., Ikeda, M., Kawamoto, K., Higashino, K., Nakano, K., Yamada, K., Ishizaki, J., and Arita, H. 2000. Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells. J. Biol. Chem., 274: 34203-34211.
8. Hayakawa, J. and Okabayashi, Y. 2004. Simultaneous analysis of phospholipid in rabbit bronchoalveolar lavage fluid by liquid chromatography/mass spectrometry. J. Pharm. Biomed. Anal., 35: 583-592.
9. Hevonoja, T., Pentikainen, M.O., Hyvonen, M.T., Kovanen, P., and Ala-Korpela, T.M. 2000. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Biochim. Biophys. Acta., 1488: 189-210.
10. Ishimoto, Y., Yamada, K., Yamamoto, S., Ono, T., Notoya, M., and Hanasaki, K. 2003. Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions. Biochim. Biophys. Acta., 1642: 129-138.
11. Jiang, X., Paultre, C.F., Pearson, T.A., Reed, R.G., Francis, C.K., Lin, M., Berglund, L., and Tall, A.R. 1985. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscl. Throm. Vas., 20: 2614-2618.
12. Kabarowski, J.H., Xu, Y., and Witte, O.N. 2002. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol., 64: 161-167.
13. Kaduce, T.L., Norton, K.C., and Spector, A.A. 1983. A rapid, isocratic method for phospholipid separation by high-performance liquid chromatography. J. Lipid Res., 24: 1398-1403.
14. Käkelä, R., Somerharju, P., and Tyynelä, J. 2003. Analysis of phospholipid molecular species in brains from patients with infantile and juvenile neuronal-ceroid lipofuscinosis using liquid chromatography-electrospray ionization mass spectrometry. J. Neurochem., 84: 1051-1065.
15. Morioka, Y., Saiga, A., Yokota, Y., Suzuki, N., Ikeda, M., Ono, T., Nakano, K., Fujii, N., Ishizaki, J., Arita, H., and Hanasaki, K. 2000. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor. Arch. Biochem. Biophys., 381: 31-42.
16. Nakashima, S., Nagata, K., Banno, Y., Sakiyama, T., Kitagawa, T., Miyawaki, S., and Nozawa, Y. 1984. A mouse model for Niemann-Pick disease: phospholipid class and fatty acid composition of various tissues. J. Lipid Res., 25: 219-227.
17. Pruzanski, W., Stefanski, E., de Beer, F.C., Ravandi, M.C.A., and Kuksis, A. 2000. Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J. Lipid Res., 41: 1035-1047.
18. Rouser, G., Fkeischer, S., and Yamamoto, A. 1970. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids, 5: 494-496.
19. Sonoki, K., Iwase, M., Iino, K., Ichikawa, K., Ohdo, S., Higuchi, S., Yoshinari, M., and Iida, M. 2003. Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor. Metabolism, 52: 308-314.
20. Taguchi, R., Hayakawa, J., Takeuchi, Y., and Ishida, M. 2000. Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry. J. Mass. Spectrom., 35: 953-966.
21. Tselepis, A.D. and Chapman, M.J. 2002. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atherosclerosis. Suppl., 3: 57-68.
22. Uran, S., Larsen, Å, Jacobsen, P.B., and Skotland, T. 2001. Analysis of phospholipid species in human blood using normal-phase liquid chromatography coupled with electrospray ionization ion-trap tandem mass spectrometry. J. Chromatogr. B., 758: 265-275.
23. Vidaver, G.A., Ting, A., and Lee, J.W. 1985. Evidence that lysolecithin is an important causal agent of atherosclerosis. J. Theor. Biol., 115: 27-41.